Neurology Advisor (7/22, Han) reports researchers found that “the genetically-mediated effects of angiotensin-converting enzyme (ACE) inhibitors showed an improvement in cognition in patients with Alzheimer’s disease dementia but not in functionality.” The findings were presented at the Alzheimer’s Association conference. (SOURCE: APA Headlines)